nifedipine has been researched along with triiodothyronine in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (28.00) | 18.7374 |
| 1990's | 7 (28.00) | 18.2507 |
| 2000's | 3 (12.00) | 29.6817 |
| 2010's | 8 (32.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Aleo, MD; Bonin, PD; Luo, Y; Potter, DM; Swiss, R; Will, Y | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| du Pont, JS | 1 |
| Kim, D; Marsh, JD; Smith, TW | 1 |
| Attali, JR; Nicolas, P; Perret, G; Uzzan, B; Valensi, P; Vassy, R | 1 |
| Chijiwa, T; Hagiwara, M; Hidaka, H; Ishikawa, T; Mamiya, S | 1 |
| Gasińska, T; Izbicka, M; Nowak, S; Szydło, E | 1 |
| Arlot, S; Lalau, JD; Miteljan, E; Quichaud, J | 1 |
| Kimlová, I; Neradilová, M; Reisenauer, R; Stárka, L; Zofková, I | 1 |
| Bednár, J; Blahos, J; Zofková, I | 1 |
| Astier, H; Grazzini, E; Guipponi, M; Roussel, JP | 1 |
| Astier, H; Grazzini, E; Rodriguez, E; Roussel, JP; Zumbihl, R | 1 |
| Gøtzsche, LB | 1 |
| Barlow, JW; Kolliniatis, E; Scholz, GH; Stockigt, JR; Topliss, DJ | 1 |
| Borman, JB; Masalha, S; Merin, G; Schwalb, H; Segal, J; Uretzky, G | 1 |
| Gondou, A; Imai, Y; Inada, M; Iwasaka, T; Matsubara, H; Mori, Y; Nishikawa, M; Toyoda, N; Yonemoto, T | 1 |
| Manley, SW; Mitchell, AM; Mortimer, RH; Powell, KA | 1 |
| Mishra, SK; Parija, SC; Raviprakash, V; Telang, AG; Varshney, VP | 1 |
| Everts, ME; Hennemann, G; Lamers, JM; Moerings, EP; Verhoeven, FA; Visser, TJ | 1 |
| Ghasemi, A; Godini, A; Zahediasl, S | 1 |
1 review(s) available for nifedipine and triiodothyronine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for nifedipine and triiodothyronine
| Article | Year |
|---|---|
Effect of nifedipine on thyrotropin, prolactin, and thyroid hormone release in man: a placebo-controlled study.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Nifedipine; Prolactin; Random Allocation; Thyroid Hormones; Thyrotropin; Thyrotropin-Releasing Hormone; Time Factors; Triiodothyronine | 1989 |
23 other study(ies) available for nifedipine and triiodothyronine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Chemical and Drug Induced Liver Injury; Humans; Male; Mitochondria, Liver; Rats; Rats, Sprague-Dawley; Severity of Illness Index | 2014 |
Triiodothyronine affects the electrical properties of GH3 cells.
Topics: Action Potentials; Animals; Apamin; Cell Line, Transformed; Cell Membrane; Electric Conductivity; Electrophysiology; Membrane Potentials; Nifedipine; Pituitary Gland; Rats; Tetraethylammonium; Tetraethylammonium Compounds; Tetrodotoxin; Triiodothyronine | 1990 |
Effect of thyroid hormone on slow calcium channel function in cultured chick ventricular cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Blockers; Cell Division; Cells, Cultured; Chick Embryo; Heart; Ion Channels; Isoproterenol; Myocardial Contraction; Nifedipine; Receptors, Adrenergic, beta; Sarcolemma; Triiodothyronine; Ventricular Function | 1987 |
Thyroid hormones directly interact with vascular smooth muscle strips.
Topics: Animals; Aorta; Calcium; Cattle; Female; In Vitro Techniques; Kinetics; Lanthanum; Mesenteric Arteries; Muscle Contraction; Muscle, Smooth, Vascular; Myosin Subfragments; Myosin-Light-Chain Kinase; Myosins; Nifedipine; Peptide Fragments; Phosphorylation; Potassium Chloride; Protein Kinases; Rabbits; Thyroxine; Triiodothyronine; Triiodothyronine, Reverse | 1989 |
[Effect of various beta-adrenolytic drugs and calcium channel blockers (nifedipine) on serum levels of T3 and T4 in patients with hyperthyroidism and simple goiter].
Topics: Adrenergic beta-Antagonists; Adult; Female; Goiter; Humans; Hyperthyroidism; Male; Middle Aged; Nifedipine; Thyroxine; Triiodothyronine | 1988 |
Effect of three days nifedipine administration on thyroid response to TSH.
Topics: Adult; Humans; Middle Aged; Nifedipine; Thyroid Gland; Thyrotropin; Thyroxine; Triiodothyronine | 1987 |
Effect of nifedipine on the adrenocortical and somatotrophic secretory reserve and TSH and thyroid hormone plasma levels.
Topics: Adrenal Cortex Hormones; Adult; Female; Growth Hormone; Humans; Hydrocortisone; Nifedipine; Thyroid Hormones; Thyrotropin; Thyroxine; Triiodothyronine; Verapamil | 1983 |
Effect of calcium antagonists on thyrotropin and thyroid hormone secretion.
Topics: Adolescent; Adult; Female; Humans; Male; Middle Aged; Nifedipine; Pyridines; Thyroid Hormones; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine; Triiodothyronine; Verapamil | 1982 |
Dihydropyridine-like effects of amiodarone and desethylamiodarone on thyrotropin secretion and intracellular calcium concentration in rat pituitary.
Topics: Amiodarone; Animals; Calcium; Calcium Channel Blockers; Cells, Cultured; Dihydropyridines; Drug Synergism; Male; Nifedipine; Peptide Fragments; Pituitary Gland; Protein Precursors; Rats; Rats, Wistar; Thyrotropin; Thyrotropin-Releasing Hormone; Triiodothyronine | 1995 |
Triiodo-L-thyronine enhances TRH-induced TSH release from perifused rat pituitaries and intracellular Ca2+ levels from dispersed pituitary cells.
Topics: Animals; Calcium; Cells, Cultured; Dose-Response Relationship, Drug; Male; Nifedipine; Pituitary Gland; Radioimmunoassay; Rats; Rats, Wistar; Thyrotropin; Thyrotropin-Releasing Hormone; Time Factors; Triiodothyronine; Verapamil | 1995 |
L-triiodothyronine acutely increases Ca2+ uptake in the isolated, perfused rat heart. Changes in L-type Ca2+ channels and beta-receptors during short- and long-term hyper- and hypothyroidism.
Topics: Animals; Binding Sites; Calcium; Calcium Channels; Dose-Response Relationship, Drug; Female; Heart; Heart Rate; Hyperthyroidism; Hypothyroidism; Male; Models, Biological; Myocardium; Nifedipine; Organ Culture Techniques; Random Allocation; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Triiodothyronine | 1994 |
Influence of calmodulin antagonists and calcium channel blockers on triiodothyronine uptake by rat hepatoma and myoblast cell lines.
Topics: Analysis of Variance; Animals; Cadmium; Calcium; Calcium Channel Blockers; Calmodulin; Cell Line; Diltiazem; Imidazoles; Iodine Radioisotopes; Liver Neoplasms, Experimental; Magnesium; Muscles; Nifedipine; Protein Kinase C; Rats; Sulfonamides; Tetradecanoylphorbol Acetate; Trifluoperazine; Triiodothyronine; Tumor Cells, Cultured; Verapamil | 1993 |
Acute effect of thyroid hormone in the rat heart: role of calcium.
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Cardiotonic Agents; Dose-Response Relationship, Drug; Heart; Heart Rate; Male; Nifedipine; Perfusion; Rats; Rats, Inbred Strains; Stimulation, Chemical; Thyroxine; Time Factors; Triiodothyronine; Verapamil | 1996 |
Type 1 iodothyronine deiodinase in heart --effects of triiodothyronine and angiotensin II on its activity and mRNA in cultured rat myocytes.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Angiotensin II; Animals; Animals, Newborn; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Cells, Cultured; Gene Expression; Iodide Peroxidase; Myocardium; Nifedipine; Potassium; Protein Kinase C; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetradecanoylphorbol Acetate; Triiodothyronine | 1999 |
Different transporters for tri-iodothyronine (T(3)) and thyroxine (T(4)) in the human choriocarcinoma cell line, JAR.
Topics: Analysis of Variance; Biological Transport; Calcium Channel Blockers; Choriocarcinoma; Cyclooxygenase Inhibitors; Diazepam; Female; GABA Modulators; Humans; Iodine Radioisotopes; Leucine; Meclofenamic Acid; Mefenamic Acid; Nifedipine; Nitrendipine; Phenylalanine; Phenytoin; Thyroxine; Triiodothyronine; Tryptophan; Tumor Cells, Cultured; Uterine Neoplasms; Verapamil | 2000 |
Influence of hypothyroid state on 45Ca(2+) influx and sensitivity of rat uterus to nifedipine and diltiazem.
Topics: Animals; Calcium; Calcium Channel Blockers; Calcium Radioisotopes; Diltiazem; Dose-Response Relationship, Drug; Female; Hypothyroidism; In Vitro Techniques; Methimazole; Muscle Contraction; Nifedipine; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Thyroxine; Triiodothyronine; Uterus | 2001 |
Inhibitory effects of calcium channel blockers on thyroid hormone uptake in neonatal rat cardiomyocytes.
Topics: Adenosine Triphosphate; Animals; Animals, Newborn; Biological Transport; Calcium; Calcium Channel Blockers; Cell Membrane; Cells, Cultured; Diltiazem; Iodine Radioisotopes; Muscle Fibers, Skeletal; Myocardium; Nifedipine; Potassium; Rats; Rats, Wistar; Thyroxine; Triiodothyronine; Verapamil | 2001 |
The Possible Mechanisms of the Impaired Insulin Secretion in Hypothyroid Rats.
Topics: Acetylcholine; Animals; Blood Glucose; Glucokinase; Glyburide; Hexokinase; Hypoglycemic Agents; Hypothyroidism; Insulin; Insulin Secretion; Islets of Langerhans; Male; Nifedipine; Rats; Rats, Wistar; Thyroxine; Triiodothyronine | 2015 |